.

LPL - PSC-SHALIMAR BAGH

Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

: Mrs. SHUCHI AGGARWAL

Lab No.

: 120968433

Age: 35 Years

A/c Status

: P

Ref By :

Gender:

DR ANIL GANJOO

Test Name

Female

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:15PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

Cholesterol Total

204.00

mg/dL

<200.00

Triglycerides

80.00

mg/dL

<150.00

HDL Cholesterol

70.00

mg/dL

40.00 - 60.00

LDL Cholesterol

118.00

mg/dL

<100.00

VLDL Cholesterol

16.00

mg/dL

<30.00

Non-HDL Cholesterol

134.00

mg/dL

COMPREHENSIVE WELLNESS ADVANCE

LIPID PROFILE, BASIC, SERUM
(Spectrophotometry, Calculated)

Interpretation
-------------------------------------------------------------------------| NCEP RECOMMENDATIONS| TOTAL CHOLESTEROL | TRIGLYCERIDE |LDL CHOLESTEROL |
|
| in mg/dL
| in mg/dL
|in mg/dL
|
|---------------------|-------------------|--------------|-----------------|
| Optimal
| <200
| <150
| <100
|
|---------------------|-------------------|--------------|-----------------|
| Above Optimal
| | | 100-129
|
|---------------------|-------------------|--------------|-----------------|
| Borderline High
| 200-239
| 150-199
| 130-159
|
|---------------------|-------------------|--------------|-----------------|
| High
| >=240
| 200-499
| 160-189
|
|---------------------|-------------------|--------------|-----------------|
| Very High
| | >=500
| >=190
|
--------------------------------------------------------------------------

Note

1. Measurements in the same patient can show physiological & analytical variations. Three serial samples
1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. As per NCEP guidelines, all adults above the age of 20 years should be screened for lipid status.
Selective screening of children above the age of 2 years with a family history of premature
cardiovascular disease or those with at least one parent with high total cholesterol is recommended.
3. NCEP identifies elevated Triglycerides as an independent risk factor for Coronary Heart Disease (CHD).
4. Low HDL levels are associated with Coronary Heart Disease due to insufficient HDL being available to
participate in reverse cholesterol transport, the process by which cholesterol is eliminated from
peripheral tissues.
5. ATP III guidelines uses LDL Cholesterol as the primary target for cholesterol lowering therapy. Note that
major risk factors can modify LDL goals.
NON HDL CHOLESTEROL
----------------------------------------------------------------------| RISK CATEGORY
| LDL GOAL (mg/dL)
| NON HDL GOAL (mg/dL) |
|----------------------|-------------------------|----------------------|
| CHD & CHD risk
| < 100
| < 130
|
| equivalent (10 year |
|
|
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)

Page 1 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

: Mrs. SHUCHI AGGARWAL

Lab No.

: 120968433

Age: 35 Years

A/c Status

: P

Ref By :

Gender:

DR ANIL GANJOO

Female

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:15PM

Report Status

: Final

Test Name
Results
Units
| risk for CHD > 20 %) |
|
|
-----------------------------------------------------------------------

Bio. Ref. Interval

----------------------------------------------------------------------| Multiple (2+) Risk

| < 130
| < 160
|
| Factors and 10 year |
|
|
| risk < or = 20%
|
|
|
|----------------------|-------------------------|----------------------|
| 0-1 Risk factor
| < 160
| <190
|
-----------------------------------------------------------------------

Comments

ATP III suggested the addition of Non HDL Cholesterol (Total Cholesterol - HDL Cholesterol) as an indicator of
all atherogenic lipoproteins (mainly LDL & VLDL). The Non HDL Cholesterol is used as a secondary target of
therapy in persons with triglycerides >=200 mg/dL. The goal for Non HDL Cholesterol in those with increased
triglyceride is 30 mg/dL above that set for LDL Cholesterol.
For calculation of CHD risk, history of smoking, any medication for hypertension & current blood pressure
levels are required.
LIVER & KIDNEY PANEL, SERUM
(Spectrophotometry, Indirect ISE)

Urea

24.00

mg/dL

17.00 - 43.00

Creatinine

0.66

mg/dL

0.51 - 0.95

Uric Acid

4.30

mg/dL

2.60 - 6.00

AST (SGOT)

16

U/L

<35

ALT (SGPT)

11

U/L

<35

GGTP

16

U/L

<38

Alkaline Phosphatase (ALP)

59

U/L

30 - 120

Bilirubin Total

0.66

mg/dL

0.30 - 1.20

Bilirubin Direct

0.13

mg/dL

<0.20

Bilirubin Indirect

0.53

mg/dL

<1.10

Total Protein

6.40

g/dL

6.40 - 8.30

Albumin

3.63

g/dL

3.50 - 5.20

A : G Ratio

1.31

Calcium, Total

8.30

mg/dL

8.80 - 10.60

Phosphorus

3.10

mg/dL

2.40 - 4.40

Sodium

133.00

mEq/L

136.00 - 146.00

Potassium

4.28

mEq/L

3.50 - 5.10

Chloride

102.00

mEq/L

101.00 - 109.00

0.90 - 2.00

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)

Page 2 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

: Mrs. SHUCHI AGGARWAL

Lab No.

: 120968433

Age: 35 Years

A/c Status

: P

Ref By :

Gender:

DR ANIL GANJOO

Test Name

Female

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:15PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

Glucose Fasting

85.00

mg/dL

70.00 - 100.00

Glucose (PP)

78.00

mg/dL

70.00 - 140.00

GLUCOSE, FASTING (F) AND POST MEAL, PLASMA

(Hexokinase)

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 4)

Page 3 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

Gender:

Female

DR ANIL GANJOO

Test Name

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:20PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E

(Automated Strip Test, Microscopy)
Physical

Colour

Light Yellow

Pale yellow

Specific Gravity

1.010

1.001 - 1.030

pH

7.5

5.0 - 8.0

Nil
Nil
Nil
Nil
Normal
Positive
Negative

Nil
Nil
Nil
Nil
Normal
Negative
Negative

R.B.C.

Negative

Negative

Pus Cells

5-7 WBC/HPF

0-5 WBC / hpf

Epithelial Cells

+(in small numbers)

Few

Casts

Nil

Nil /lpf

Crystals

Nil

Nil

Others

Amorphous Phosphate :
+

Chemical

Proteins
Glucose
Ketones
Bilirubin
Urobilinogen
Leucocyte Esterase
Nitrite
Microscopy

PatientReportSCSuperPanel.URINE_EXAMINATION_SC (Version: 4)

Page 4 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

Gender:

Female

DR ANIL GANJOO

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:24PM

Report Status

: Final

Test Name

Results

Units

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD

(HPLC, NGSP certified)

4.90

Bio. Ref. Interval

Interpretation
------------------------------------------------------------------------------|
As per American Diabetes Association (ADA)
|
|-------------------------------------------------------------------------------|
| Reference Group
| HbA1c in %
|
|-------------------------------|-----------------------------------------------|
| Non diabetic adults >=18 years| <5.7
|
|-------------------------------|-----------------------------------------------|
| At risk (Prediabetes)
| 5.7 - 6.4
|
|-------------------------------|-----------------------------------------------|
| Diagnosing Diabetes
| >= 6.5
|
|-------------------------------|-----------------------------------------------|
| Therapeutic goals for glycemic| Age > 19 years
|
| control
| . Goal of therapy: < 7.0
|
|
| . Action suggested: > 8.0
|
|
|
|
|
| Age < 19 years
|
|
| . Goal of therapy: <7.5
|
-------------------------------------------------------------------------------

Note: 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a

diabetic patient who is recently under good control may still have a high concentration of
HbA1c. Converse is true for a diabetic previously under good control but now poorly
controlled .
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long
life expectancy and no significant cardiovascular disease. In patients with significant
complications of diabetes, limited life expectancy or extensive co-morbid conditions,
targeting a goal of < 7.0 % may not be appropriate.
Comments

HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better
indicator of long term glycemic control as compared to blood and urinary glucose determinations.
ADA criteria for correlation between HbA1c & Mean plasma glucose levels
--------------------------------------| HbA1c(%) | Mean Plasma Glucose (mg/dL)|
|----------|----------------------------|
| 6
| 126
|
|----------|----------------------------|
| 7
| 154
|
|----------|----------------------------|
| 8
| 183
|
|----------|----------------------------|
| 9
| 212
|
PatientReportSCSuperPanel.HBELECTRO_SC (Version: 5)

Page 5 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

Test Name

Gender:

Female

DR ANIL GANJOO

Results
|----------|----------------------------|
| 10
| 240
|
|----------|----------------------------|
| 11
| 269
|
|----------|----------------------------|
| 12
| 298
|
---------------------------------------

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:24PM

Report Status

: Final

Units

Bio. Ref. Interval

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 5)

Page 6 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

: Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

Gender:

Female

DR ANIL GANJOO

Test Name

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:28PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

Hemoglobin

11.80

g/dL

11.50 - 15.00

Packed Cell Volume (PCV)

35.60

36.00 - 46.00

RBC Count

4.19

mill/mm3

3.80 - 4.80

MCV

85.00

fL

80.00 - 100.00

MCH

28.30

pg

27.00 - 32.00

MCHC

33.20

g/dL

32.00 - 35.00

Red Cell Distribution Width (RDW)

14.10

11.50 - 14.50

Total Leukocyte Count (TLC)

5.60

thou/mm3

4.00 - 10.00

Segmented Neutrophils

61.50

40.00 - 80.00

Lymphocytes

24.40

20.00 - 40.00

Monocytes

9.00

2.00 - 10.00

Eosinophils

4.60

1.00 - 6.00

Basophils

0.50

<2.00

Neutrophils

3.44

thou/mm3

2.00 - 7.00

Lymphocytes

1.37

thou/mm3

1.00 - 3.00

Monocytes

0.50

thou/mm3

0.20 - 1.00

Eosinophils

0.26

thou/mm3

0.02 - 0.50

Basophils

0.03

thou/mm3

0.01 - 0.10

Platelet Count

302.0

thou/mm3

150.00 - 450.00

ESR

17

mm/hr

0 - 20

HEMOGRAM
(Electrical Impendance & VCS, Capillary photometry)

Differential Leucocyte Count (DLC)

Absolute Leucocyte Count

Note

1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

PatientReportSCSuperPanel.CBC_SC (Version: 4)

Page 7 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

Gender:

DR ANIL GANJOO

Female

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:31PM

Report Status

: Final

Test Name

Results

Units

Bio. Ref. Interval

CARDIO C-REACTIVE PROTEIN (hsCRP), SERUM

(Immunoturbidimetry)

1.30

mg/L

<1.00

Interpretation
-------------------------------------------------------------| CARDIO CRP IN mg/L
| CARDIOVASCULAR RISK
|
|-----------------------|--------------------------------------|
|
<1
| Low
|
|-----------------------|--------------------------------------|
|
1-3
| Average
|
|-----------------------|--------------------------------------|
|
3-10
| High
|
|-----------------------|--------------------------------------|
|
>10
| Persistent elevation may represent
|
|
| Non cardiovascular inflammation
|
--------------------------------------------------------------

Note:

To assess vascular risk, it is recommended to test hsCRP levels 2 or more weeks apart and
calculate the average

Comments

High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a
strongest predictor of future coronary events. It reveals the risk of future Myocardial infarction and Stroke
among healthy men and women, independent of traditional risk factors. It identifies patients at risk of first
Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular events also
correlates well with hsCRP levels. It is a powerful independent risk determinant in the prediction of incident
Diabetes.
THYROID PROFILE, FREE, SERUM
(CLIA)

T3, Free; FT3

2.84

pg/mL

2.30 - 4.20

T4, Free; FT4

1.00

ng/dL

0.89 - 1.76

TSH, Ultrasensitive

2.162

uIU/mL

0.550 - 4.780

Reference Ranges for pregnancy

------------------------------------------------------------------------| PREGNANCY
| REFERENCE RANGE for TSH in | REFERENCE
|REFERENCE
|
|
| uIU/mL (As per American
| RANGE for FT3|RANGE for FT4 |
|
| Thyroid Association)
| in pg/mL
|in ng/dL
|
|-------------|----------------------------|--------------|---------------|
|1st Trimester| 0.100 - 2.500
| 2.11-3.83
|0.70 -2.00
|
|-------------|----------------------------|--------------|---------------|
|2st Trimester| 0.200 - 3.000
| 1.96-3.38
|0.50 -1.60
|
|-------------|----------------------------|--------------|---------------|
|3st Trimester| 0.300 - 3.000
| 1.96-3.38
|0.50 -1.60
|
--------------------------------------------------------------------------

Note

1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 8 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

Gender:

DR ANIL GANJOO

Test Name

Female

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:31PM

Report Status

: Final

Results

Units

Bio. Ref. Interval

minimum between 6-10 pm. The variation is of the order of 50%. hence time of the day has influence
on the measured serum TSH concentrations.
2. TSH Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals
Clinical Use

Primary Hypothyroidism
Hyperthyroidism
Hypothalamic - Pituitary hypothyroidism
Inappropriate TSH secretion
Nonthyroidal illness
Autoimmune thyroid disease
Pregnancy associated thyroid disorders
Thyroid dysfunction in infancy and early childhood

VITAMIN D, 25 - HYDROXY, SERUM

(CLIA)

34.39

nmol/L

Interpretation
------------------------------------------------------------| LEVEL
| REFERENCE RANGE | COMMENTS
|
|
| IN nmol/L
|
|
|---------------|-----------------|---------------------------|
| Deficient
| < 50
| High risk for developing |
|
|
| bone disease
|
|---------------|-----------------|---------------------------|
| Insufficient | 50-74
| Vitamin D concentration
|
|
|
| which normalizes
|
|
|
| Parathyroid hormone
|
|
|
| concentration
|
|---------------|-----------------|---------------------------|
| Sufficient
| 75-250
| Optimal concentration
|
|
|
| for maximal health benefit|
|---------------|-----------------|---------------------------|
| Potential
| >250
| High risk for toxic
|
| intoxication |
| effects
|
-------------------------------------------------------------

Note

The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.

25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.

Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.

It shows seasonal variation, with values being 40-50% lower in winter than in summer.

Levels vary with age and are increased in pregnancy.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 9 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

DR ANIL GANJOO

Test Name

Gender:

Results

Female

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:31PM

Report Status

: Final

Units

Bio. Ref. Interval

The recommended test for evaluation of 25 Hydroxy Vitamin D is by LC-MS/MS

Comments

Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency
in children causes Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and
Tetany. Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major
circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).
Decreased Levels

Inadequate exposure to sunlight

Dietary deficiency

Vitamin D malabsorption

Severe Hepatocellular disease

Drugs like Anticonvulsants

Nephrotic syndrome

Increased levels

Vitamin D intoxication
IRON STUDIES, SERUM
(Spectrophotometry)

Iron

27.00

g/dL

50.00 - 170.00

Total Iron Binding Capacity

330.00

g/dL

250.00 - 425.00

Transferrin Saturation

8.18

15.00 - 50.00

Comments
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to
microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.
Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.
Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no
unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.
VITAMIN B12; CYANOCOBALAMIN, SERUM
(CLIA)

231.00

pg/mL

211.00 - 911.00

Note: To differentiate vitamin B12 & folate deficiency, measurement of Methyl malonic acid in urine & serum
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 10 of 11

.
LPL - PSC-SHALIMAR BAGH
Shop No. A1/BQ Market,
Shalimar Bagh, De lhi-110088.
DELHI

Name

Mrs. SHUCHI AGGARWAL

Lab No.

120968433

Age: 35 Years

A/c Status

Ref By :

Female

Gender:

DR ANIL GANJOO

Test Name

Results

Collected
Received
Reported

: 6/6/2015 10:18:00AM
: 6/6/2015 10:22:39AM
: 6/6/2015 6:48:31PM

Report Status

: Final

Units

Bio. Ref. Interval

Homocysteine level is suggested

Comments

Vitamin B12 performs many important functions in the body, but the most significant function is
co-enzyme for reducing ribonucleotides to deoxyribonucleotides, a step in the formation of genes.
dietary intake is not the commonest cause for cobalamine deficiency. The most common
malabsorption either due to atrophy of gastric mucosa or diseases of terminal ileum. Cobalamine
leads to Megaloblastic anemia and demyelination of large nerve fibres of spinal cord. Normal body
sufficient to last for 3-6 years. Sources of Vitamin B12 are liver, shellfish, fish, meat, eggs, milk,
yogurt.

to act as
Inadequate
cause is
deficiency
stores are
cheese &

Decreased Levels

Lack of Intrinsic factor: Total or partial gastrectomy, Atrophic gastritis, Intrinsic factor antibodies

Malabsorption: Regional ileitis, resected bowel, Tropical Sprue, Celiac disease, pancreatic

insufficiency, bacterial overgrowth & achlorhydria

Loss of ingested vitamin B12: fish tapeworm

Dietary deficiency: Vegetarians

Congenital disorders: Orotic aciduria & transcobalamine deficiency

Increased demand: Pregnancy specially last trimester

Increased Levels

Chronic renal failure, Congestive heart failure, Acute & Chronic Myeloid Leukemia, Polycythemia vera,
Carcinomas with liver metastasis, Liver disease, Drug induced cholestasis & Protein malnutrition

Dr. Nimmi Kansal

MD (Biochemistry)
HOD Biochem & IA

Dr. Shalabh Malik

MD (Microbiology)
HOD Micro & Clinical Path

Dr. Sushrut Pownikar

DNB (Pathology)
HOD Hemat & Imm

-------------------------------End of report --------------------------------

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 5)

Page 11 of 11